Vascepa Gains European Filing Nod

No Rush In Search For Marketing Partner

 
• By Andrew McConaghie

On the cusp of US approval, Amarin must wait until late 2020 for EMA judgement

Blood_Test_Syringe
Approved in the US since 2012, Vascepa looks set to become a blockbuster

More from Cardiovascular

More from Therapy Areas